PGRN 2023 Annual Scientific Meeting

“Pushing Boundaries in Pharmacogenomics Discovery and Implementation”

June 12-13, 2023

St. Jude Children’s Research Hospital

Memphis, TN

Register early (200 person capacity)!

Discounted registration fees for the first 100 registrants

PGRN Annual Meeting 2023 Registration

Participants are invited to submit abstracts for the poster sessions. Please send your abstract to abstracts2023@pgrn.org.

Abstract Submission guidelines:

• Submission Deadline: April 14th, 2023 at 3pm Eastern Time
• Required Sections: Authors, Institutions, Background, Methods, Results, Conclusions
• 1 figure or table may be included
• Word limit: 500 words

Please note that submitting an abstract does not register you for this meeting.

Agenda

Monday, June 12

7am – 8am: registration and breakfast

8:00am-8:05am: Opening remarks

8:05am-9:50am Session 1 - "Revolutionizing Precision Medicine with Advanced Genomic Analysis and Data Science"

• Automated Genomic Data Analysis Using AI
  A/Prof Kee Yuan Ngiam, M.D., National University Hospital Singapore

•  Understanding Kidney Function Is Really Important in Pharmacogenomics — So Why Do We Settle for Inadequate Measurements and Inappropriate Polygenic Risk Scores for Kidney Function? 
  Nancy Cox, Ph.D., Vanderbilt University medical Center
  
  
• Leveraging real-world clinico-genomics and data science to advance precision oncology. 
  James Zou, Ph.D., Stanford University

•  Oral Abstract (15 mins)
  
  9:50am-10:10am Break
  
  10:10am-11:55am Session 2 - "Innovative Technologies for Functional Genomics and Single-Cell Profiling"
• High Throughput Functional Annotation of Pharmacogene Variants
  Maitreya Dunahm, Ph.D., University of Washington
  
  
•  In Search of New Targeted Therapies for Medulloblastoma.
  Tamra Werbowetski-Ogilive, University of Manitoba
  
  
•  Powering Forward Genetics Using Multiplexed Single-Cell Sequencing
  Chun (Jimme) Ye, Ph.D.
  
  
• Oral Abstract (15 mins)
  
  12:00pm-1:00pm Lunch
  
  12:15pm – 12:50pm- Town Hall
• ClinPGx:  A Single Integrated PGx Resource 
  Teri Klein, Ph.D., Stanford University
  
  1:00pm- 2:45pm Session 3 - "Transformative New Models for Understanding the Interplay of Genetics and Drug Response"
  
  
• Validating the pharmacogenomics of doxorubicin-induced cardiotoxicity 
  Paul Burridge, Ph.D., Northwestern University

 2:45pm-3:00pm Break

3:00pm-5:15pm Session 4 – "Overcoming Barriers to Pharmacogenomic and Genomic Medicine Implementation"

• Polygenic Risk Score for Coronary Artery Diseases Across Multiple Populations: Challenge and Opportunity 
  

Catherine Tcheandjieu Gueliatcha, Ph.D., University of California San Francisco

• NHGRI’s Efforts to Advance Genomic Medicine Implementation

Erin Ramos, Ph.D., MPH, National Human Genome Research Institute

• Demonstrating Clinical Utility of Pharmacogenetic Testing: A STRIPE Initiative 
  Jai Patel, Pharm.D., Atrium Health Levine Cancer Institute
  
  
•   Implementing PGx panel testing in Europe: results from the U-PGx PREPARE Study
  Jesse J. Swen, Pharm.D., Ph.D., Leiden University Medical Center  Oral abstract (15 mins)
  
  5:15pm – 6:30pm Poster session – in person only, wine/cheese

Tuesday, June 13

8am – 8:45am: registration and breakfast

8:45am – 9am- Closing remarks/meeting room information

9:00am-12:00pm Concurrent Sessions

• All of Us half day workshop
• Consecutive workshops: Pharmacogenomics Research Resources (PharmCAT, PharmGKB, PharmVar) followed by Oncology and Psychiatry Interest Groups

12:00pm- End of conference, boxed lunches for pickup in Marlo Thomas Atrium